News and Events
AMGEN’S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
THOUSAND OAKS, Calif., Nov. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful reductions in major adverse cardiovascular events (MACE) in high-risk adults without a prior heart attack or stroke, when added to statins or other low-density lipoprotein cholesterol [...]
ABC Hosts Three Signature Events at AHA25 in New Orleans on November 8
ABC Events at AHA 2025 – Saturday, November 8 | New Orleans The Association of Black Cardiologists (ABC) is excited to host three signature events on Saturday, November 8, during the 2025 American Heart Association Scientific Sessions (AHA25) in New Orleans. Attendees will have the opportunity to engage with leading experts, hear cutting-edge research, and participate in [...]
ABC Wants to Spotlight You at AHA25 — Submit Your Session Info by Nov. 5
Are you chairing, moderating, presenting, or participating in a panel at the AHA Scientific Sessions 2025 in New Orleans? Let your ABC colleagues know where to find you! ABC is spotlighting member contributions throughout AHA25 to highlight the important work and leadership of our community. Submission Deadline: Monday, November 5 at 11:59 PM ET
ABC Members Featured Among Faculty for the Masters of Medicine 2026 Conference in Jamaica
ABC Members Featured Among Faculty for the Masters of Medicine 2026 Conference in Jamaica The Masters of Medicine 2026 Conference will take place January 16–18, 2026, at the AC Hotel Kingston in Jamaica, bringing together leading experts, innovators, and healthcare professionals from around the world. Centered on the theme “Bridging the Divide: Tackling Obesity and Genetic Heart Disease in [...]
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
AstraZeneca today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access their prescribed medications at a transparent cash price with home delivery. AstraZeneca Direct will support people living with chronic conditions such as asthma, diabetes, heart failure and chronic kidney disease, and people seeking flu protection. [...]
LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS
THOUSAND OAKS, Calif., Oct. 2, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Phase 3 VESALIUS-CV clinical trial met its dual primary endpoints demonstrating that Repatha® (evolocumab) significantly reduced the risk of major adverse cardiovascular events (MACE) in individuals without a prior history of heart attack or stroke. The landmark Phase 3 VESALIUS-CV trial enrolled over 12,000 high-risk patients, [...]
Upcoming Events
Masters of Medicine 2026 Conference in Jamaica
January 16, 2026 - January 18, 20266th Annual National Sarasota Congress on Cardiovascular Disease Prevention
February 6, 2026 - February 7, 2026